Literature DB >> 15639469

Can stem cells mend a broken heart?

Siamak Davani1, Frédéric Deschaseaux, David Chalmers, Pierre Tiberghien, Jean-Pierre Kantelip.   

Abstract

Myocardial infarction is the leading cause of heart failure in developed countries. The therapeutic measures of today are usually not sufficient to prevent left ventricular remodelling as they fall short of actual replacement of necrotic cardiac myocytes. However, current insights into stem cell plasticity have opened up new perspectives for regenerating the infarcted heart. Recently, a wide range of stem/progenitor cell types have been used for cardiac cell therapy (CCT), including embryonic or foetal stem cells, myoblasts, and bone marrow stem cells. To date, the choice of stem cells has yet to be optimised. This review details recent experimental data and discusses the clinical potential of the various stem cell sources for CCT.

Entities:  

Mesh：

Year:  2005        PMID： 15639469     DOI： 10.1016/j.cardiores.2004.10.037

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


  10 in total

1.  Endothelial cells regulate cardiomyocyte development from embryonic stem cells.

Authors:  Kang Chen; Hao Bai; Melanie Arzigian; Yong-Xing Gao; Jing Bao; Wen-Shu Wu; Wei-Feng Shen; Liqun Wu; Zack Z Wang
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

Review 2.  Heart repair and stem cells.

Authors:  Linda W van Laake; Rutger Hassink; Pieter A Doevendans; Christine Mummery
Journal:  J Physiol       Date:  2006-09-28       Impact factor: 5.182

3.  Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Y Wang; H E Johnsen; S Mortensen; L Bindslev; R Sejersten Ripa; M Haack-Sørensen; E Jørgensen; W Fang; J Kastrup
Journal:  Heart       Date:  2005-10-26       Impact factor: 5.994

Review 4.  The mobilization of autologous bone marrow stem cells in the treatment of heart failure with Chinese medicine.

Authors:  Kui-Wu Yao; Liang-Deng Zhang; Jie Wang
Journal:  Chin J Integr Med       Date:  2011-08-01       Impact factor: 1.978

Review 5.  Cardiomyocyte death in doxorubicin-induced cardiotoxicity.

Authors:  Yi-Wei Zhang; Jianjian Shi; Yuan-Jian Li; Lei Wei
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-10-29       Impact factor: 4.291

Review 6.  Cellular replacement therapy for arrhythmia treatment: early clinical experience.

Authors:  Demosthenes Katritsis
Journal:  J Interv Card Electrophysiol       Date:  2008-04-01       Impact factor: 1.900

7.  Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction.

Authors:  Bilal B Ayach; Makoto Yoshimitsu; Fayez Dawood; Mei Sun; Sara Arab; Manyin Chen; Koji Higuchi; Christopher Siatskas; Paul Lee; Hilda Lim; Jane Zhang; Eva Cukerman; William L Stanford; Jeffrey A Medin; Peter P Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-07       Impact factor: 11.205

Review 8.  Stem cell therapies for the treatment of radiation-induced normal tissue side effects.

Authors:  Marc Benderitter; Fabio Caviggioli; Alain Chapel; Robert P Coppes; Chandan Guha; Marco Klinger; Olivier Malard; Fiona Stewart; Radia Tamarat; Peter van Luijk; Charles L Limoli
Journal:  Antioxid Redox Signal       Date:  2014-02-03       Impact factor: 8.401

Review 9.  Bone marrow mononuclear cells and acute myocardial infarction.

Authors:  Samer Arnous; Abdul Mozid; John Martin; Anthony Mathur
Journal:  Stem Cell Res Ther       Date:  2012-01-17       Impact factor: 6.832

10.  High frequencies of adaptive NK cells are associated with absence of coronary plaque in cytomegalovirus infected people living with HIV.

Authors:  Khlood Alsulami; Manel Sadouni; Daniel Tremblay-Sher; Jean-Guy Baril; Benoit Trottier; Franck P Dupuy; Carl Chartrand-Lefebvre; Cécile Tremblay; Madeleine Durand; Nicole F Bernard
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.